Patent details

Basic Information

Publication number:

EP2134854

PCT Application Number:

PCT/US/2008/003369

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP087268108

PCT Publication Number:

WO/2008/115404

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

TREATMENT METHOD USING EGFR ANTIBODIES AND SRC INHIBITORS AND RELATED FORMULATIONS

French Title of Invention:

PROCÉDÉ DE TRAITEMENT UTILISANT DES ANTICORPS ANTI-EGFR ET DES INHIBITEURS DE SRC, ET LEUR FORMULATIONS

German Title of Invention:

BEHANDLUNGSVERFAHREN UNTER VERWENDUNG VON EGFR-ANTIKÖRPERN UND SRC-INHIBITOREN UND DAMIT VERBUNDENE FORMULIERUNGEN

SPC Number:

Dates

Filing date:

14/03/2008

Grant date:

15/04/2015

EP Publication Date:

15/04/2015

PCT Publication Date:

25/09/2008

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

23/12/2009

EP B1 Publication Date:

15/04/2015

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/03/2016

Expiration date:

14/03/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

14/03/2008

 

 

Name:

Ludwig Institute for Cancer Research Ltd.

Address:

605 Third Avenue, New York, NY 10158, United States (US)

Inventor

1

Name:

CAVENEE Webster

Address:

United States (US)

2

Name:

FURNARI Frank

Address:

United States (US)

3

Name:

SCOTT Andrew

Address:

Australia (AU)

4

Name:

JOHNS Terrance, Grant

Address:

Australia (AU)

Priority

Priority Number:

918084 P

Priority Date:

15/03/2007

Priority Country:

United States (US)

Classification

Main IPC Class:

C12P 21/08;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages